Trial Profile
A phase 3, prospective, open, pilot, monocentric study to evaluate the effect of sulodexide administered at registered dose on morphology and functional properties of the venous endothelium in patients with chronic venous insufficiency.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 29 Sep 2016
Price :
$35
*
At a glance
- Drugs Sulodexide (Primary)
- Indications Venous insufficiency
- Focus Pharmacodynamics
- Sponsors Alfa Wassermann SpA
- 29 Sep 2016 New trial record